journal
Journals Therapeutic Advances in Respir...

Therapeutic Advances in Respiratory Disease

https://read.qxmd.com/read/38877686/prescriptions-of-opioid-containing-drugs-in-patients-with-chronic-cough
#21
JOURNAL ARTICLE
Michael Weiner, Ziyue Liu, Jonathan Schelfhout, Paul Dexter, Anna R Roberts, Ashley Griffith, Vishal Bali, Jessica Weaver
BACKGROUND: Chronic cough (CC) affects about 10% of adults, but opioid use in CC is not well understood. OBJECTIVES: To determine the use of opioid-containing cough suppressant (OCCS) prescriptions in patients with CC using electronic health records. DESIGN: Retrospective cohort study. METHODS: Through retrospective analysis of Midwestern U.S. electronic health records, diagnoses, prescriptions, and natural language processing identified CC - at least three medical encounters with cough, with 56-120 days between first and last encounter - and a 'non-chronic cohort'...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38856049/clinical-presentation-and-treatment-of-four-children-with-pulmonary-mucoepidermoid-carcinoma
#22
JOURNAL ARTICLE
Yiting Yang, Quan Wang, Zhengxia Pan, Hongbo Li, Yong An, Chun Wu
Primary lung cancer in childhood is extremely rare, with an incidence rate of less than 2/100,0000, and pulmonary mucoepidermoid carcinoma (PMEC), is even rarer. Their symptoms are usually not specific, and there are no guidelines for their management, which makes their clinical management a challenge for pediatricians. The purpose of this report is to discuss the clinical presentation, positive signs, examinations, pathological characteristics, surgical modalities, chemotherapy regimens, and prognosis in children...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38841799/relationships-between-symptoms-and-lung-function-in-asthma-and-or-chronic-obstructive-pulmonary-disease-in-a-real-life-setting-the-novel-observational-longitudinal-study
#23
MULTICENTER STUDY
Alberto Papi, Rod Hughes, Ricardo Del Olmo, Alvar Agusti, Bradley E Chipps, Barry Make, Erin Tomaszewski, Keith Peres Da Costa, Divyansh Srivastava, Jørgen Vestbo, Christer Janson, Pierre-Régis Burgel, David Price
BACKGROUND: The relationships between spirometric assessment of lung function and symptoms (including exacerbations) in patients with asthma and/or chronic obstructive pulmonary disease (COPD) in a real-life setting are uncertain. OBJECTIVES: To assess the relationships between baseline post-bronchodilator (post-BD) spirometry measures of lung function and symptoms and exacerbations in patients with a physician-assigned diagnosis of asthma and/or COPD. DESIGN: The NOVEL observational longiTudinal studY (NOVELTY) is a global, prospective, 3-year observational study...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38817020/impact-of-line-probe-assay-based-molecular-testing-on-individualized-treatment-in-patients-with-rifampicin-resistant-tuberculosis-data-from-the-prospective-innova4tb-cohort-study-in-ukraine
#24
JOURNAL ARTICLE
Andrii Dudnyk, Matthias Hempel, Oksana Lytvyniuk, Halyna Liudkevych, Volodymyr Matsera, Tetiana Nikitchenko, Svitlana Blyzniuk, Barbara Molina-Moya, Rosemarie Preyer, José Domínguez
BACKGROUND: Ukraine remains a high World Health Organization priority country for drug-resistant tuberculosis (TB). Rifampicin-resistant TB (RR-TB) has a more protracted, more complicated, and more expensive treatment. In 2021, Ukraine reported 4025 RR-TB cases - 5.4 times more (751) than all 30 European Union/ European Economic Area countries together. OBJECTIVES: The objective of the study was to determine the diagnostic accuracy of line probe assay (LPA), AID Autoimmun Diagnostika GmbH, for detecting resistance to anti-TB drugs and its clinical application for selecting treatment regimens...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38804685/safety-and-efficacy-of-bronchial-thermoplasty-in-refractory-asthma-with-severe-obstructive-respiratory-dysfunction
#25
JOURNAL ARTICLE
Takahiro Inoue, Sumito Isogai, Naoki Yamamoto, Noriko Hiramatsu, Yoshikazu Niwa, Hideaki Takahashi, Yutaro Kimura, Tomoya Horiguchi, Yasuhiro Goto, Naozumi Hashimoto, Kazuyoshi Imaizumi
BACKGROUND: Bronchial thermoplasty (BT) is a recently developed non-pharmacological therapy for refractory bronchial asthma. Although increasing evidence has suggested that BT is effective for various phenotypes of severe asthma, its safety and efficacy in patients with severe irreversible impaired lung function are unclear. OBJECTIVES: To assess the efficacy and safety of BT in patients with refractory asthma, including patients with a severely impaired forced expiratory volume in 1 second (FEV1)...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38803144/building-and-validating-an-artificial-intelligence-model-to-identify-tracheobronchopathia-osteochondroplastica-by-using-bronchoscopic-images
#26
JOURNAL ARTICLE
Chongxiang Chen, Fei Tang, Felix J F Herth, Yingnan Zuo, Jiangtao Ren, Shuaiqi Zhang, Wenhua Jian, Chunli Tang, Shiyue Li
BACKGROUND: Given the rarity of tracheobronchopathia osteochondroplastica (TO), many young doctors in primary hospitals are unable to identify TO based on bronchoscopy findings. OBJECTIVES: To build an artificial intelligence (AI) model for differentiating TO from other multinodular airway diseases by using bronchoscopic images. DESIGN: We designed the study by comparing the imaging data of patients undergoing bronchoscopy from January 2010 to October 2022 by using EfficientNet...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38785071/combined-medical-interventional-approaches-for-the-management-of-complex-fungal-balls-a-case-series-as-a-viable-alternative-in-non-surgical-patients
#27
JOURNAL ARTICLE
Elaine Dumoulin, Christina S Thornton, John H MacGregor, Alain Tremblay, Chrystal Chan, Paul R MacEachern, Margaret M Kelly, Ranjani Somayaji, Michael D Parkins, Christopher H Mody
Intracavitary pulmonary aspergilloma is a persistent and life-threatening infection that carries a mortality rate of up to 15%. It occurs when Aspergillus species gain entry to an existing lung cavity. In the absence of definitive treatment, patients may succumb to severe complications such as massive hemoptysis, cachexia, or secondary infections. Aspergillomas often show limited response to antifungal medications, mainly due to insufficient drug concentrations within the cavities. Surgery is frequently the preferred treatment option, but it poses significant risks, and many individuals are ineligible due to underlying health issues...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38785036/treatment-of-mixed-and-refractory-post-tuberculosis-tracheobronchial-stenosis-with-l-shaped-silicone-stents-case-series-and-a-literature-review
#28
REVIEW
Changwen Zhang, Wentao Li, Yu Li, Ni Fang, Mingpeng Xu, Lan Ke, Lifang Li, Guangnan Liu
The two patients included in the study had mixed and refractory post-tuberculosis tracheobronchial stenosis (PTTS), having experienced unsuccessful interventional therapies such as balloon dilation and V-shaped stent placement before the operation. Following the secure placement of L-shaped silicone stents, examinations with a fiberbronchoscope during the first and third months post-operation revealed a significant reduction in bronchial mucosa inflammation for both patients. Additionally, the opening diameter of the upper and lower branch segments increased, and chest CT scans indicated a noticeable absorption of left pulmonary lesions...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38780228/impact-of-lumacaftor-ivacaftor-on-the-bacterial-and-fungal-respiratory-pathogens-in-cystic-fibrosis-a-prospective-multicenter-cohort-study-in-sweden
#29
MULTICENTER STUDY
Mahasin Al Shakirchi, Kimmo Sorjonen, Lena Hjelte, Lena Klingspor, Peter Bergman, Petrea Ericson, Marcus Svedberg, Ulrika Lindberg, Christine Hansen, Isabelle de Monestrol
BACKGROUND: A significant decline in pulmonary exacerbation rates has been reported in CF patients homozygous for F508del treated with lumacaftor/ivacaftor. However, it is still unclear whether this reduction reflects a diminished microbiological burden. OBJECTIVES: The aim of this study was to determine the impact of lumacaftor/ivacaftor on the bacterial and fungal burden. DESIGN: The study is a prospective multicenter cohort study including 132 CF patients homozygous for F508del treated with lumacaftor/ivacaftor...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38780129/sex-related-disparities-in-cough-associated-symptoms-across-different-age-groups
#30
MULTICENTER STUDY
Jiyeon Kang, Woo Jung Seo, Jung Gon Kim, Ji-Yong Moon, Deog Kyeom Kim, Jin Woo Kim, Seung Hun Jang, Jae-Woo Kwon, Byung-Jae Lee, Hyeon-Kyoung Koo
BACKGROUND: Sex-related disparities in the prevalence of chronic cough have been consistently reported globally, with varying male-to-female ratios. OBJECTIVES: This study aimed to evaluate sex-related differences by comparing correlations between cough-related symptoms in males and females of different age groups. DESIGN: Adult patients with chronic cough who completed the Leicester Cough Questionnaire (LCQ) were recruited from 16 respiratory centers...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38757948/prognostic-value-of-serum-oncomarkers-for-patients-hospitalized-with-acute-exacerbation-of-interstitial-lung-disease
#31
JOURNAL ARTICLE
Cuirong Ba, Chunguo Jiang, Huijuan Wang, Xuhua Shi, Jiawei Jin, Qiuhong Fang
BACKGROUND: Different types of inflammatory processes and fibrosis have been implicated in the pathogenesis of interstitial lung disease (ILD), a heterogeneous, diffuse, parenchymal lung disease. Acute exacerbation (AE) of ILD is characterized by significant respiratory deterioration and is associated with high mortality rates. Several serum oncomarkers have been used to determine the prognosis of ILD; however, the prognostic value of serum oncomarker levels in patients with AE-ILD remains unclear...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38757628/a-combination-of-radiomic-features-clinic-characteristics-and-serum-tumor-biomarkers-to-predict-the-possibility-of-the-micropapillary-solid-component-of-lung-adenocarcinoma
#32
JOURNAL ARTICLE
Xiaowei Xing, Liangping Li, Mingxia Sun, Xinhai Zhu, Yue Feng
BACKGROUND: Invasive lung adenocarcinoma with MPP/SOL components has a poor prognosis and often shows a tendency to recurrence and metastasis. This poor prognosis may require adjustment of treatment strategies. Preoperative identification is essential for decision-making for subsequent treatment. OBJECTIVE: This study aimed to preoperatively predict the probability of MPP/SOL components in lung adenocarcinomas by a comprehensive model that includes radiomics features, clinical characteristics, and serum tumor biomarkers...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38757612/diagnostic-yield-using-electromagnetic-navigation-bronchoscopy-for-peripheral-pulmonary-nodules-2%C3%A2-cm
#33
JOURNAL ARTICLE
Jun-Ying Chen, Han Yang, Xiao-Dan Lin, Hong Yang, Jing Wen, Qian-Wen Liu, Lan-Jun Zhang, Peng Lin, Jian-Hua Fu, Chang-Sen Leng, Rong Yi, Kong-Jia Luo
BACKGROUND: Although electromagnetic navigation bronchoscopy (ENB) is highly sensitive in the diagnosis of peripheral pulmonary nodules (PPNs), its diagnostic yield for subgroups of smaller PPNs is under evaluation. OBJECTIVES: Diagnostic yield evaluation of biopsy using ENB for PPNs <2 cm. DESIGN: The diagnostic yield, sensitivity, specificity, positive predictive value, and negative predictive value of the ENB-mediated biopsy for PPNs were evaluated...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38726850/comparison-of-limited-driving-pressure-ventilation-and-low-tidal-volume-strategies-in-adults-with-acute-respiratory-failure-on-mechanical-ventilation-a-randomized-controlled-trial
#34
RANDOMIZED CONTROLLED TRIAL
Surat Tongyoo, Tanuwong Viarasilpa, Phitphiboon Deawtrakulchai, Santi Subpinyo, Chaiyawat Suppasilp, Chairat Permpikul
BACKGROUND: Ventilator-induced lung injury (VILI) presents a grave risk to acute respiratory failure patients undergoing mechanical ventilation. Low tidal volume (LTV) ventilation has been advocated as a protective strategy against VILI. However, the effectiveness of limited driving pressure (plateau pressure minus positive end-expiratory pressure) remains unclear. OBJECTIVES: This study evaluated the efficacy of LTV against limited driving pressure in preventing VILI in adults with respiratory failure...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38698565/albuterol-budesonide-fixed-dose-combination-rescue-inhaler-for-asthma-a-plain-language-summary-of-the-mandala-study
#35
REVIEW
Alberto Papi, Bradley E Chipps, Richard Beasley, Reynold A Panettieri, Elliot Israel, Mark Cooper, Lynn Dunsire, Allison Jeynes-Ellis, Robert Rees, Frank C Albers, Christy Cappelletti
What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38676370/impression-life-with-pulmonary-hypertension-clinically-relevant-characteristics-and-quality-of-life-among-patients-in-gansu-china
#36
JOURNAL ARTICLE
Juxia Zhang, Yujie Wen, Yuhuan Yin, Yiyin Zhang, Rong Zhang, Xiaoli Zhang, Jianying Ye, Yuping Feng, Hongyan Meng
BACKGROUND: The adverse effects of pulmonary arterial hypertension (PAH) on physical, emotional, and health-related quality of life (HRQoL) remain primarily unrecognized, especially in resource-limited settings. OBJECTIVES: This study aims to characterize the HRQoL of patients with PAH in this area and also identify the potential role of clinically relevant characteristics, including the 6-min walk distance test (6MWD), WHO-Functional Classification (WHO-FC), and mental health in the occurrence of lowering quality of life...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38660953/effects-of-a-pulmonary-rehabilitation-program-on-pulmonary-function-exercise-performance-and-quality-of-life-in-patients-with-severe-covid-19
#37
JOURNAL ARTICLE
María Fernanda Del Valle, Jorge Valenzuela, Claudio Bascour-Sandoval, Gabriel Nasri Marzuca-Nassr, Mariano Del Sol, Constanza Díaz Canales, Máximo Escobar-Cabello, Rodrigo Lizama-Pérez, Fernando Valenzuela-Aedo, Rodrigo Muñoz-Cofré
BACKGROUND: Severe coronavirus 2019 disease (COVID-19) causes acute hypoxemic respiratory failure requiring invasive mechanical ventilation (IMV). Once these symptoms are resolved, patients can present systemic deterioration. OBJECTIVE: The two objectives of this study were as follows: to describe the results of a pulmonary rehabilitation program (PRP), which is divided into three groups with different numbers of sessions (12, 24, and 36), and to associate the variables of pulmonary function, exercise performance, and functionality with the number of sessions and functional improvement...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38659187/optimal-flow-of-high-flow-nasal-cannula-oxygenation-to-prevent-desaturation-during-sedation-for-bronchoscopy-a-randomized-controlled-study
#38
RANDOMIZED CONTROLLED TRIAL
Wen Zhang, Xiaohong Yuan, Yajian Shen, Jiangling Wang, Kangjie Xie, Xinzhong Chen
BACKGROUND: Although high-flow nasal cannula (HFNC) oxygenation is currently recommended to prevent desaturation during sedation for bronchoscopy, there is no consensus on an optimal flow rate. OBJECTIVE: To determine the optimal oxygen flow rate for HFNC to effectively prevent desaturation during sedation for bronchoscopy. DESIGN: Prospective, randomized, and controlled study. METHODS: Patients ( n  = 240) scheduled for bronchoscopy were randomized to receive HFNC with propofol sedation (fraction of inspired oxygen, 100%) at one of six flow rates of 10, 20, 30, 40, 50, and 60 L/min, designated as groups 1-6, respectively...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38616385/novel-application-of-nanomedicine-for-the-treatment-of-acute-lung-injury-a-literature-review
#39
REVIEW
Xianfeng Chen, Zhanhong Tang
Nanoparticles have attracted extensive attention due to their high degree of cell targeting, biocompatibility, controllable biological activity, and outstanding pharmacokinetics. Changing the size, morphology, and surface chemical groups of nanoparticles can increase the biological distribution of agents to achieve precise tissue targeting and optimize therapeutic effects. Examples of their use include nanoparticles designed for increasing antigen-specific immune responses, developing vaccines, and treating inflammatory diseases...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38554035/perceived-burden-of-respiratory-physiotherapy-in-people-with-cystic-fibrosis-taking-elexacaftor-tezacaftor-ivacaftor-combination-a-1-year-observational-study
#40
JOURNAL ARTICLE
Chiara Blardone, Simone Gambazza, Alessandra Mariani, Rachele Galgani, Anna Brivio, Rita Maria Nobili, Carmela Rizza, Anna Luisa Tutino, Andrea Gramegna, Valeria Daccò, Martina Contarini, Francesco Blasi, Dario Laquintana
BACKGROUND: To limit the progression of disease, people with cystic fibrosis (pwCF) perform daily respiratory physiotherapy, which is perceived as the most burdensome routine in managing their condition. The elexacaftor-tezacaftor-ivacaftor (ETI) combination has changed respiratory management. OBJECTIVE: To investigate how the perceived treatment burden changed in 1 year of treatment with ETI. DESIGN: Prospective observational study...
2024: Therapeutic Advances in Respiratory Disease
journal
journal
41742
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.